Li-Wei Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li-Wei Cho has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Ben Jen-Min Ng
Changi Gen Hosp, Singapore 529889, Singapore
1 shared publication- Chen Yuan Tud Richard
Changi General Hospital
1 shared publication - Eberta Tan
Department of Endocrinology, Changi General Hospital, Simei, Singapore
1 shared publication - Joan Khoo
Department of Endocrinology, Changi General Hospital, Singapore, Singapore
1 shared publication - Joo-Pin Foo
Changi Gen Hosp, Singapore 529889, Singapore
1 shared publication - Shui Boon Soh
The Alfred
1 shared publication
Latest Publications
- 1 March 2012
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 26 (2) , 99-101
Sensitivity of A1C to diagnose diabetes is decreased in high-risk older Southeast Asians
- 1 March 2012
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 26 (2) , 99-101
Sensitivity of A1C to diagnose diabetes is decreased in high-risk older Southeast Asians
- 1 November 2011
- Vol. 52 (11) , 779-785
Metabolic syndrome
Metabolic syndrome is a clustering of different risk factors that collectively increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. The syndrome itself is associated with various metabolic abnormalities, including insulin resistance, non-alcoholic fatty liver disease, obstructive sleep apnoea, male hypogonadism and polycystic ovary syndrome. This review aims to discuss recent developments related to the syndrome, including the associated metabolic complications and goals for therapeutic strategies.
- 1 November 2011
- Vol. 52 (11) , 779-785
Metabolic syndrome
Metabolic syndrome is a clustering of different risk factors that collectively increases the risk of developing cardiovascular disease and type 2 diabetes mellitus. The syndrome itself is associated with various metabolic abnormalities, including insulin resistance, non-alcoholic fatty liver disease, obstructive sleep apnoea, male hypogonadism and polycystic ovary syndrome. This review aims to discuss recent developments related to the syndrome, including the associated metabolic complications and goals for therapeutic strategies.